14.24 USD
↘ 0.15 (1.04%)AT CLOSE (11:59 AM EDT)
Greenwich LifeSciences, Inc.
GLSINASDAQ • USD
14.24
↘ 0.01 (0.04%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
14.24
↘ 0.01 (0.04%)
Market: CLOSED
GLSI is currently priced at $14.36. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$14.31
High?$14.97
Low?$14.24
Prev. Close?$14.39
Volume?87.6K
Avg. Volume?180.1K
VWAP?$14.47
Rel. Volume?0.49x
Bid / Ask
Bid?$12.21 × 100
Ask?$17.30 × 100
Spread?$5.09
Midpoint?$14.76
Valuation & Ratios
Market Cap?211.2M
Shares Out?14.7M
Float?5.9M
Float %?42.3%
P/E Ratio?N/A
P/B Ratio?40.08
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.
Employees
13
Market Cap
211.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-09-25
Address
3992 BLUEBONNET DR, BUILDING 14
STAFFORD, TX 77477
Phone: 203-434-3290
STAFFORD, TX 77477
Phone: 203-434-3290
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?5.57Safe
Confidence?40%Low
Short InterestSqueeze Risk
Short % of Float?25.06%Squeeze Risk
Short Interest?1.5M
Days to Cover?12.1
Free Float5.9M
Avg Daily Volume121.1K
Settlement Date2026-07-15
Financial Health
Current Ratio?2.01Strong
Quick Ratio?2.01Strong
Cash Ratio?2.01Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?40.08HIGH▾
Peers100
S&P3
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-9.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-412.8%WEAK▾
S&P3
ROA?-207.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$200.7M
Fundamentals ratios updated end of day